Aktive Positionen von Daniel Fischer
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Tevard Biosciences, Inc.
 Tevard Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Tevard Biosciences, Inc. is a biotechnology company based in Cambridge, MA. Tevard Biosciences is focused on developing trna-based and other modulating therapies to cure a broad range of genetic diseases. The company is advancing the use of its novel suppressor trna, enhancer trna, and mrna amplifier platforms in neurological disorders, heart disease, and muscular dystrophies. The company was founded in 2017 by Warren Burt Lammert, Harvey F. Lodish, Daniel Fischer, and Jeffrey Coller. Daniel Fischer has been the CEO since 2017. | Direktor/Vorstandsmitglied | 31.08.2017 | - |
| Vorstandsvorsitzender | 31.08.2017 | - | |
| Gründer | 31.08.2017 | - | |
| Präsident | 31.08.2017 | - |
Karriereverlauf von Daniel Fischer
Statistik
International
| Vereinigte Staaten | 2 |
Operativ
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Founder | 1 |
Sektoral
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Tevard Biosciences, Inc.
Tevard Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Tevard Biosciences, Inc. is a biotechnology company based in Cambridge, MA. Tevard Biosciences is focused on developing trna-based and other modulating therapies to cure a broad range of genetic diseases. The company is advancing the use of its novel suppressor trna, enhancer trna, and mrna amplifier platforms in neurological disorders, heart disease, and muscular dystrophies. The company was founded in 2017 by Warren Burt Lammert, Harvey F. Lodish, Daniel Fischer, and Jeffrey Coller. Daniel Fischer has been the CEO since 2017. | Commercial Services |
- Börse
- Insiders
- Daniel Fischer
- Erfahrung
